Cargando…
Novel Therapeutics for Diabetic Retinopathy and Diabetic Macular Edema: A Pathophysiologic Perspective
Diabetic retinopathy (DR) and diabetic macular edema (DME) are retinal complications of diabetes that can lead to loss of vision and impaired quality of life. The current gold standard therapies for treatment of DR and DME focus on advanced disease, are invasive, expensive, and can trigger adverse s...
Autores principales: | Bunch, Katharine L., Abdelrahman, Ammar A., Caldwell, Ruth B., Caldwell, R. William |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894892/ https://www.ncbi.nlm.nih.gov/pubmed/35250632 http://dx.doi.org/10.3389/fphys.2022.831616 |
Ejemplares similares
-
Systemic Administration of Pegylated Arginase-1 Attenuates the Progression of Diabetic Retinopathy
por: Abdelrahman, Ammar A., et al.
Publicado: (2022) -
Is the Arginase Pathway a Novel Therapeutic Avenue for Diabetic Retinopathy?
por: Shosha, Esraa, et al.
Publicado: (2020) -
Novel imaging biomarkers in diabetic retinopathy and diabetic macular edema
por: Markan, Ashish, et al.
Publicado: (2020) -
Targeting the Pathophysiology of Diabetic Macular Edema
por: Romero-Aroca, Pedro
Publicado: (2010) -
Current and Novel Therapeutic Approaches for Treatment of Diabetic Macular Edema
por: Chauhan, Muhammad Z., et al.
Publicado: (2022)